• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hyperferritinemia in critically ill COVID-19 patients - Is ferritin the product of inflammation or a pathogenic mediator?

作者信息

Gómez-Pastora Jenifer, Weigand Mitchell, Kim James, Wu Xian, Strayer Jacob, Palmer Andre F, Zborowski Maciej, Yazer Mark, Chalmers Jeffrey J

机构信息

William G. Lowrie Department of Chemical and Biomolecular Engineering, The Ohio State University, 151 West Woodruff Avenue, Columbus, OH 43210, United States.

Department of Biomedical Engineering, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, United States.

出版信息

Clin Chim Acta. 2020 Oct;509:249-251. doi: 10.1016/j.cca.2020.06.033. Epub 2020 Jun 21.

DOI:10.1016/j.cca.2020.06.033
PMID:32579952
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7306200/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6168/7306200/096e3ae7deac/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6168/7306200/096e3ae7deac/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6168/7306200/096e3ae7deac/gr1_lrg.jpg

相似文献

1
Hyperferritinemia in critically ill COVID-19 patients - Is ferritin the product of inflammation or a pathogenic mediator?危重症COVID-19患者的高铁蛋白血症——铁蛋白是炎症产物还是致病介质？
Clin Chim Acta. 2020 Oct;509:249-251. doi: 10.1016/j.cca.2020.06.033. Epub 2020 Jun 21.
2
COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy.
Immunol Res. 2020 Aug;68(4):213-224. doi: 10.1007/s12026-020-09145-5.
3
Two consecutive myocardial tissue insults for inpatients with COVID-19.新型冠状病毒肺炎住院患者的连续两次心肌组织损伤。
Crit Care. 2020 May 26;24(1):259. doi: 10.1186/s13054-020-02981-9.
4
The association between biomarkers and clinical outcomes in novel coronavirus pneumonia in a US cohort.美国队列中新型冠状病毒肺炎生物标志物与临床结局的关联。
Biomark Med. 2020 Aug;14(12):1091-1097. doi: 10.2217/bmm-2020-0309. Epub 2020 Jul 17.
5
COVID-19 Coagulopathy and Inflammation: The Knowns and Unknowns.新型冠状病毒肺炎凝血功能障碍与炎症：已知与未知
Anesth Analg. 2020 Nov;131(5):1323. doi: 10.1213/ANE.0000000000005215.
6
SARS-CoV-2-related atypical thyroiditis.与严重急性呼吸综合征冠状病毒2相关的非典型甲状腺炎
Lancet Diabetes Endocrinol. 2020 Sep;8(9):739-741. doi: 10.1016/S2213-8587(20)30266-7. Epub 2020 Jul 30.
7
Venous Thrombosis Among Critically Ill Patients With Coronavirus Disease 2019 (COVID-19).新冠肺炎危重症患者的静脉血栓栓塞症。
JAMA Netw Open. 2020 May 1;3(5):e2010478. doi: 10.1001/jamanetworkopen.2020.10478.
8
Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis.心血管疾病作为新冠病毒感染风险增加及相关不良预后的生物标志物。
Biomark Med. 2020 Jun;14(9):713-716. doi: 10.2217/bmm-2020-0201. Epub 2020 May 19.
9
Cautious interpretation of antiphospholipid antibodies in COVID-19.对新冠病毒肺炎中抗磷脂抗体的谨慎解读
Clin Chim Acta. 2020 Oct;509:166. doi: 10.1016/j.cca.2020.06.024. Epub 2020 Jun 15.
10
ISTH interim guidance on recognition and management of coagulopathy in COVID-19.国际血栓与止血学会（ISTH）关于新冠病毒病（COVID-19）凝血病识别与管理的临时指南。
J Thromb Haemost. 2020 May;18(5):1023-1026. doi: 10.1111/jth.14810. Epub 2020 Apr 27.

引用本文的文献

1
Ferritin's role in infectious diseases: Exploring pathogenic mechanisms and clinical implications.铁蛋白在传染病中的作用：探索致病机制与临床意义。
New Microbes New Infect. 2025 Mar 20;65:101582. doi: 10.1016/j.nmni.2025.101582. eCollection 2025 Jun.
2
The relationship between gut and nasopharyngeal microbiome composition can predict the severity of COVID-19.肠道微生物群与鼻咽微生物群组成之间的关系可以预测新冠肺炎的严重程度。
Elife. 2025 Feb 18;13:RP95292. doi: 10.7554/eLife.95292.
3
Predictive value of ANE-SS combined with ferritin and DIC scores for mortality Risk in children with acute necrotizing encephalopathy.

本文引用的文献

1
The role of interleukin-6 in monitoring severe case of coronavirus disease 2019.白细胞介素-6 在监测 2019 年冠状病毒病重症病例中的作用。
EMBO Mol Med. 2020 Jul 7;12(7):e12421. doi: 10.15252/emmm.202012421. Epub 2020 Jun 5.
2
Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients.SARS-CoV-2 感染患者外周血淋巴细胞反应和细胞因子谱的纵向特征。
EBioMedicine. 2020 May;55:102763. doi: 10.1016/j.ebiom.2020.102763. Epub 2020 Apr 18.
3
Clinical and immunological features of severe and moderate coronavirus disease 2019.
ANE-SS联合铁蛋白和DIC评分对急性坏死性脑病患儿死亡风险的预测价值
Transl Pediatr. 2025 Jan 24;14(1):42-51. doi: 10.21037/tp-24-416. Epub 2025 Jan 21.
4
The recombinant spike S1 protein induces injury and inflammation in co-cultures of human alveolar epithelial cells and macrophages.重组刺突S1蛋白在人肺泡上皮细胞和巨噬细胞共培养物中诱导损伤和炎症。
PLoS One. 2025 Feb 10;20(2):e0318881. doi: 10.1371/journal.pone.0318881. eCollection 2025.
5
Taurolithocholic acid protects against viral haemorrhagic fever via inhibition of ferroptosis.牛磺胆酸通过抑制铁死亡来预防病毒性出血热。
Nat Microbiol. 2024 Oct;9(10):2583-2599. doi: 10.1038/s41564-024-01801-y. Epub 2024 Sep 18.
6
The Role of Vitamins, Magnesium, and Trace Elements in COVID-19 Treatment and Post-COVID-19 Rehabilitation: An Updated Overview.维生素、镁和微量元素在新冠病毒疾病治疗及新冠康复后的作用：最新综述
Curr Med Chem. 2025;32(16):3134-3154. doi: 10.2174/0109298673301578240515095227.
7
Frontiers and hotspots evolution in cytokine storm: A bibliometric analysis from 2004 to 2022.细胞因子风暴的前沿与热点演变：2004年至2022年的文献计量分析
Heliyon. 2024 May 10;10(10):e30955. doi: 10.1016/j.heliyon.2024.e30955. eCollection 2024 May 30.
8
Is it possible to identify COVID-19 infection-related biomarkers during pregnancy?: A prospective study in Turkish population.是否有可能在怀孕期间识别与 COVID-19 感染相关的生物标志物？：一项在土耳其人群中的前瞻性研究。
Medicine (Baltimore). 2024 May 10;103(19):e38062. doi: 10.1097/MD.0000000000038062.
9
Redox Homeostasis Alteration Is Restored through Melatonin Treatment in COVID-19 Patients: A Preliminary Study.褪黑素治疗可恢复新冠患者的氧化还原稳态改变：一项初步研究
Int J Mol Sci. 2024 Apr 21;25(8):4543. doi: 10.3390/ijms25084543.
10
Low iron mitigates viral survival: insights from evolution, genetics, and pandemics-a review of current hypothesis.低铁水平可减轻病毒存活：来自进化、遗传学和大流行的见解——当前假说综述
Egypt J Med Hum Genet. 2020;21(1):75. doi: 10.1186/s43042-020-00114-z. Epub 2020 Dec 16.
新型冠状病毒病 2019 重症和中度患者的临床和免疫学特征。
J Clin Invest. 2020 May 1;130(5):2620-2629. doi: 10.1172/JCI137244.
4
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study.113 例新冠肺炎死亡患者的临床特征：回顾性研究。
BMJ. 2020 Mar 26;368:m1091. doi: 10.1136/bmj.m1091.
5
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
6
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.中国武汉 2019 年冠状病毒病（COVID-19）患者免疫反应失调。
Clin Infect Dis. 2020 Jul 28;71(15):762-768. doi: 10.1093/cid/ciaa248.
7
Hyperferritinemia and inflammation.高血铁症与炎症。
Int Immunol. 2017 Nov 1;29(9):401-409. doi: 10.1093/intimm/dxx031.
8
The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome.高铁蛋白血症综合征：巨噬细胞活化综合征、斯蒂尔病、感染性休克和灾难性抗磷脂综合征。
BMC Med. 2013 Aug 22;11:185. doi: 10.1186/1741-7015-11-185.